Millennium Management’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Millennium Management’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-130,155	Closed	-$81K	–	4587
2018 Q4	$81K	Sell	130,155 -294,061	-69%	-$305K	﹤0.01%	3569
2018 Q3	$551K	Sell	424,216 -66,559	-14%	-$103K	﹤0.01%	3195
2018 Q2	$663K	Buy	+490,775	New	+$752K	﹤0.01%	3039
2018 Q1	–	Sell	-58,727	Closed	-$132K	–	4404
2017 Q4	$132K	Buy	+58,727	New	+$149K	﹤0.01%	3611
2017 Q2	–	Sell	-23,222	Closed	-$79K	–	4218
2017 Q1	$79K	Buy	+23,222	New	+$90.3K	﹤0.01%	3347
2015 Q3	–	Sell	-134,102	Closed	-$617K	–	4061
2015 Q2	$617K	Buy	134,102 +78,685	+142%	+$754K	﹤0.01%	2522
2015 Q1	$374K	Buy	+55,417	New	+$274K	﹤0.01%	2914

Millennium Management's AST Position: Q1 2019 in Review

Millennium Management sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 130,155 shares — an estimated $81K sold.

Millennium Management first reported a position in AST in Q1 2015 and held it in 7 quarters. The position peaked at $663K in Q2 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

Millennium Management reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
Millennium Management sold 130,155 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $81K.
Millennium Management first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2015 and held it in 7 quarters.
Millennium Management's Asterias Biotherapeutics Inc. Series A position peaked at $663K in Q2 2018.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.